HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Angel R Fuentes-Pesquera Selected Research

1- (4- (6- amino- 5- (methoxyiminomethyl)pyrimidin- 4- yloxy)- 2- chlorophenyl)- 3- ethylurea

1/2009A highly selective, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor has potent activity in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Angel R Fuentes-Pesquera Research Topics

Disease

4Neoplasms (Cancer)
04/2009 - 08/2007
1Neoplasm Metastasis (Metastasis)
01/2009
1Corneal Neovascularization
01/2009

Drug/Important Bio-Agent (IBA)

1ErbB Receptors (EGF Receptor)IBA
04/2009
1Tyrosine Kinase InhibitorsIBA
04/2009
1pyrimidineIBA
04/2009
11- (4- (6- amino- 5- (methoxyiminomethyl)pyrimidin- 4- yloxy)- 2- chlorophenyl)- 3- ethylureaIBA
01/2009
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
01/2009
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2009
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
01/2009
1pyrazoleIBA
08/2007
1benzocycloheptapyridineIBA
08/2007